Jonathan Bush, CEO of Zus Health, sat down with Barron's Andy Serwer to discuss his various health-care ventures as well as the chronic challenges facing the U.S. health-care system.
 Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

Jonathan Bush, CEO of Zus Health, sat down with Barron's Andy Serwer to discuss his various health-care ventures as well as the chronic challenges facing the U.S. health-care system. Learn more about your ad choices. Visit megaphone.fm/adchoices

Jonathan Bush, CEO of Zus Health, sat down with Barron's Andy Serwer to discuss his various health-care ventures as well as the chronic challenges facing the U.S. health-care system.
 Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices" rel="noopener noreferrer">megaphone.fm/adchoices</a>

Jonathan Bush on Zus Health, Athena Health, and How to Fix Health Care

Join Barron’s Andy Serwer as he sits down with top CEOs and business leaders to discuss the biggest stories in business, including the economy, emerging technologies such as artificial intelligence, leadership, corporate culture, and more. Every week, our guests offer unique insight into their companies and the broader corporate world to help you see around corners and understand what's next. At Barron’s also unpacks the human side of top executives, including the challenges and experiences that made them into the leaders they are today.

Share Jonathan Bush on Zus Health, Athena Health, and How to Fix Health Care

Sign up to save your podcasts

Jonathan Bush on Zus Health, Athena Health, and How to Fix Health Care

Jonathan Bush on Zus Health, Athena Health, and How to Fix Health Care

More shows like At Barron's

WSJ Your Money Briefing

Investing Insights

WSJ What’s News

Odd Lots

Capital Ideas Podcast

Wall Street Breakfast

Numbers by Barron's

The Readback

Thoughts on the Market

The Journal.

Wall Street Week

Barron's Streetwise

Barron's Advisor

Barron's Live

Investing Experts

The Markets

WSJ's Take On the Week